PNC Financial Services Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

PNC Financial Services Group’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-34	Closed	–	–	4214
2019 Q3	$0	Sell	34 -5,000	-99%	-$81K	﹤0.01%	4202
2019 Q2	$71K	Hold	5,034	–	–	﹤0.01%	2744
2019 Q1	$44K	Hold	5,034	–	–	﹤0.01%	3020
2018 Q4	$38K	Buy	5,034 +5,000	+14,706%	+$80.5K	﹤0.01%	3014
2018 Q3	$0	Hold	34	–	–	﹤0.01%	4318
2018 Q2	$2K	Hold	34	–	–	﹤0.01%	4022
2018 Q1	$0	Hold	34	–	–	﹤0.01%	4343
2017 Q4	$0	Buy	+34	New	+$932	﹤0.01%	4313

PNC Financial Services Group's DOVA Position: Q4 2019 in Review

PNC Financial Services Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 34 shares.

PNC Financial Services Group first reported a position in DOVA in Q4 2017 and held it in 8 quarters. The position peaked at $71K in Q2 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

PNC Financial Services Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
PNC Financial Services Group sold 34 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019.
PNC Financial Services Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
PNC Financial Services Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $71K in Q2 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on PNC Financial Services Group's 13F filing for Q4 2019, filed 7 Feb 2020.